Pages that link to "Item:Q4335635"
From MaRDI portal
The following pages link to Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials (Q4335635):
Displaying 20 items.
- On the maximum total sample size of a group sequential test about bivariate binomial propor\-tions (Q544640) (← links)
- Exact power calculations for detecting hypotheses involving two correlated binary outcomes (Q871013) (← links)
- A review of phase 2-3 clinical trial designs (Q1029784) (← links)
- Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials (Q1727847) (← links)
- Efficacy and toxicity monitoring via Bayesian predictive probabilities in phase II clinical trials (Q2059113) (← links)
- A curtailed procedure for selecting among treatments with two Bernoulli endpoints (Q2135601) (← links)
- Some geometric methods for constructing decision criteria based on two-dimensional parame\-ters (Q2475737) (← links)
- Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology (Q3078865) (← links)
- Monitoring the Rates of Composite Events with Censored Data in Phase II Clinical Trials (Q3078908) (← links)
- Directed Walk Designs for Dose-Response Problems with Competing Failure Modes (Q3079102) (← links)
- Testing Statistical Hypotheses on Stochastic Ordering of Discrete Distributions (Q3094211) (← links)
- Treatment Comparisons Based on Two‐Dimensional Safety and Efficacy Alternatives in Oncology Trials (Q4666639) (← links)
- Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes (Q4666685) (← links)
- Bayesian randomized clinical trials: A decision-theoretic sequential design (Q4673116) (← links)
- A Bayesian Group Sequential Approach for Multiple Endpoints (Q4678861) (← links)
- Two-stage phase II trials with early stopping for effectiveness and safety as well as ineffectiveness or harm (Q5076974) (← links)
- Finding confidence bound using two-stage data (Q5160236) (← links)
- Ethical issues in oncology biostatistics (Q5424159) (← links)
- A Geometric Approach to Comparing Treatments for Rapidly Fatal Diseases (Q5473225) (← links)
- Group sequential designs for clinical trials with bivariate endpoints (Q6629838) (← links)
